Skip to content

Multicenter Cohort Study on Screening for Type 2 Diabetes and Its Complications in Adults in Hubei ProvinceEnglish Acronym

Multicenter Cohort Study on Screening for Type 2 Diabetes and Its Complications in Adults in Hubei ProvinceEnglish Acronym

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090785
Enrollment
Unknown
Registered
2024-10-13
Start date
2024-10-14
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes and Its Complications in Adults

Interventions

Observation group:None

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Participants in this study must be aged between 18 and 65 years and belong to a high-risk group for diabetes, meeting at least one of the following conditions: body mass index (BMI) = 25 kg/m²; fasting blood glucose = 5.7 mmol/L; 1-hour post-glucose (PG) = 7.0 mmol/L; dyslipidemia; hypertension (= 140/90 mmHg), or cardiovascular or cerebrovascular diseases; a family history of type 2 diabetes; or a history of gestational diabetes or polycystic ovary syndrome. Additionally, all participants must be willing to sign an informed consent form and agree to follow-up.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: This study will exclude participants who meet the following conditions: those diagnosed with type 1 diabetes; those currently undergoing antidepressant treatment; and those with various severe illnesses, such as pancreatitis, liver cancer, severe digestive system diseases, post-surgical patients, and other cancer patients that may affect blood glucose levels.

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobin (HbA1c);Total cholesterol;Triglycerides;High-density lipoprotein cholesterol (HDL-C);Low-density lipoprotein cholesterol (LDL-C);Alanine aminotransferase (ALT);Aspartate aminotransferase (AST);Total bilirubin;Direct bilirubin;Urine glucose;Urine protein;Urine creatinine;Urine pH;

Secondary

MeasureTime frame
Height;Weight;Blood pressure;Pulse rate;White blood cell count;Neutrophil count;Red blood cell count;Red blood cell count;Platelet count;Serum albumin;Serum globulin;Stool color;Stool consistency;Stool white blood cells;Stool red blood cells;Stool fat globules;

Countries

China

Contacts

Public ContactLing Gao

Renmin Hospital of Wuhan University

ling.gao@whu.edu.cn+86 159 2746 9449

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026